Functional improvement in mouse models of familial amyotrophic lateral sclerosis by PEGylated insulin-like growth factor I treatment depends on disease severity-Reference-Cited by-同舟云学术

Functional improvement in mouse models of familial amyotrophic lateral sclerosis by PEGylated insulin-like growth factor I treatment depends on disease severity

Published:2012-08-07 Issue:5 Volume:13 Page:418-429
ISSN:1748-2968
Container-title:Amyotrophic Lateral Sclerosis
language:en
Short-container-title:Amyotrophic Lateral Sclerosis

Author:

Saenger Stefanie,Holtmann Bettina,Nilges Mark R.,Schroeder Susanne,Hoeflich Andreas,Kletzl Heidemarie,Spooren Will,Ostrowitzki Susanne,Hanania Taleen,Sendtner Michael,Metzger Friedrich

Publisher

Informa UK Limited

Subject

Neurology (clinical),Neurology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/17482968.2012.679944

Reference41 articles.

1. Linkage of a Gene Causing Familial Amyotrophic Lateral Sclerosis to Chromosome 21 and Evidence of Genetic-Locus Heterogeneity

2. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS

3. Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of ultrasound-mediated blood-spinal cord barrier opening on survival and motor function in females in an amyotrophic lateral sclerosis mouse model;eBioMedicine;2024-08

2. Neurotrophic Factors as Regenerative Therapy for Neurodegenerative Diseases: Current Status, Challenges and Future Perspectives;International Journal of Molecular Sciences;2023-02-15

3. IGF-1 as a Potential Therapy for Spinocerebellar Ataxia Type 3;Biomedicines;2022-02-21

4. Possibilities of Combinatorial Therapy: Insulin Dysregulation and the Growth Hormone Perspective on Neurodegeneration;Pharmacogenetics;2021-11-24

5. Motor Neuron Diseases and Neuroprotective Peptides: A Closer Look to Neurons;Frontiers in Aging Neuroscience;2021-09-17